Literature DB >> 3404186

Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease.

T M Li1, E Alberman, M Swash.   

Abstract

A review of 580 hospital case notes of patients with motor neuron disease (MND) revealed 20 families in which more than one case had been reported. For 27 of the cases in these families full medical records were available, and a history of a further 37 affected family members were obtained. The cases in these 20 families are termed familial and the remainder sporadic. Parent to child transmission occurred in 16 of the 20 families of the familial cases, suggesting autosomal dominant inheritance. In three families there was involvement of siblings only, and in one family two cousins were affected. The sex ratio for the documented familial case records seen was 0.8:1 (M/F = 12:15), for the total (documented and historical) it was 1.06:1 (33:31), but in sporadic cases it was 1.6:1 (341:212) and more frequent occurrence of sensory features at presentation was reported in the familial cases (15% in the familial cases and 5% in the sporadic cases). However, none of these differences reached statistical significance. Familial cases also differed from sporadic cases in having a younger age of onset (a mean of 52 years in the familial cases compared with 56 years in the sporadic) and in the shorter median reported duration of illness (1.1 year in the familial cases; 2.6 years in the sporadic). However, in only one fifth of sporadic cases was the age at onset and death known, although this was known for 22 of the 27 familial cases, so that the data on survival and age of onset are too incomplete to test formally.

Entities:  

Mesh:

Year:  1988        PMID: 3404186      PMCID: PMC1033147          DOI: 10.1136/jnnp.51.6.778

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form?

Authors:  W K ENGEL; L T KURLAND; I KLATZO
Journal:  Brain       Date:  1959-06       Impact factor: 13.501

2.  Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics.

Authors:  M Jokelainen
Journal:  Acta Neurol Scand       Date:  1977-09       Impact factor: 3.209

3.  Familial motor neuron disease. Evidence for at least three different types.

Authors:  W A Horton; R Eldridge; J A Brody
Journal:  Neurology       Date:  1976-05       Impact factor: 9.910

Review 4.  Epidemiology of motor-neuron diseases.

Authors:  A R Bobowick; J A Brody
Journal:  N Engl J Med       Date:  1973-05-17       Impact factor: 91.245

5.  Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

Authors:  W R Kennedy; M Alter; J H Sung
Journal:  Neurology       Date:  1968-07       Impact factor: 9.910

6.  Hereditary amyotrophic lateral sclerosis. Histochemical and electron microscopic study of hyaline inclusions in motor neurons.

Authors:  K Takahashi; H Nakamura; E Okada
Journal:  Arch Neurol       Date:  1972-10

7.  Concordance for amyotrophic lateral sclerosis in a pair of dizygous twins of consanguineous parents.

Authors:  J Dumon; J Macken; T De Barsy
Journal:  J Med Genet       Date:  1971-03       Impact factor: 6.318

8.  Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells.

Authors:  A Hirano; L T Kurland; G P Sayre
Journal:  Arch Neurol       Date:  1967-03

9.  Amyotrophic lateral sclerosis. Clinical features and prognosis.

Authors:  A D Rosen
Journal:  Arch Neurol       Date:  1978-10

10.  Amyotrophic lateral sclerosis in dizygotic twins.

Authors:  W J Estrin
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

View more
  23 in total

Review 1.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 2.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 3.  British motor neuron disease twin study.

Authors:  A J Graham; A M Macdonald; C H Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study.

Authors:  R Gregory; K Mills; M Donaghy
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

Review 5.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

6.  Amyotrophic lateral sclerosis: update and new developments.

Authors:  Ashley J Pratt; Elizabeth D Getzoff; J Jefferson P Perry
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-02

7.  Intricate interplay between astrocytes and motor neurons in ALS.

Authors:  Hemali P Phatnani; Paolo Guarnieri; Brad A Friedman; Monica A Carrasco; Michael Muratet; Sean O'Keeffe; Chiamaka Nwakeze; Florencia Pauli-Behn; Kimberly M Newberry; Sarah K Meadows; Juan Carlos Tapia; Richard M Myers; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

8.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; R J Swingler; S M Holloway; C P Warlow
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

Review 9.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.